Aberdeen Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$11.9M Buy
137,011
+2,548
+2% +$216K 0.04% 336
2017
Q1
$12M Sell
134,463
-5,137
-4% -$428K 0.04% 314
2016
Q4
$10.3M Sell
139,600
-9,724
-7% -$728K 0.04% 322
2016
Q3
$11.3M Sell
149,324
-2,584
-2% -$198K 0.04% 302
2016
Q2
$11.7M Sell
151,908
-3,577
-2% -$282K 0.04% 283
2016
Q1
$12.1M Sell
155,485
-14,396
-8% -$1.01M 0.04% 263
2015
Q4
$11.2M Buy
169,881
+17,067
+11% +$1.19M 0.04% 270
2015
Q3
$11.8M Buy
152,814
+4,782
+3% +$423K 0.04% 230
2015
Q2
$13.4M Sell
148,032
-3,419
-2% -$274K 0.04% 225
2015
Q1
$11.4M Buy
151,451
+72,027
+91% +$5.17M 0.03% 239
2014
Q4
$5.83M Hold
79,424
0.01% 348
2014
Q3
$5.6M Hold
79,424
0.01% 411
2014
Q2
$4.48M Buy
79,424
+25,993
+49% +$1.37M 0.01% 486
2014
Q1
$2.81M Buy
+53,431
New +$2.66M 0.01% 283

Other funds holding HCA

Aberdeen Asset Management's HCA Position: Q2 2017 in Review

Aberdeen Asset Management increased its HCA Healthcare (HCA) stake by 1.9% in Q2 2017, buying an estimated $216K and bringing the position to 137,011 shares worth $11.9M. The position accounts for 0.04% of the portfolio, ranked #336.

Aberdeen Asset Management first reported a position in HCA in Q1 2014 and has held it in 14 quarters since. The position peaked at $13.4M in Q2 2015. 570 funds tracked by Wall St. Rank hold HCA as of Q2 2017.

  • Aberdeen Asset Management held 137,011 shares of HCA Healthcare worth $11.9M as of Q2 2017.
  • Aberdeen Asset Management bought 2,548 HCA Healthcare shares in Q2 2017, an estimated $216K.
  • HCA Healthcare made up 0.04% of Aberdeen Asset Management's portfolio in Q2 2017, its #336 holding.
  • Aberdeen Asset Management first reported a position in HCA Healthcare in Q1 2014 and has held it in 14 quarters since.
  • Aberdeen Asset Management's HCA Healthcare position peaked at $13.4M in Q2 2015.
  • 570 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.